EAGLE PHARMACEUTICALS, INC. Quarterly Depreciation in USD from Q4 2013 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Eagle Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from Q4 2013 to Q1 2023.
  • Eagle Pharmaceuticals, Inc. Depreciation for the quarter ending March 31, 2023 was $110K, a 37.9% decline year-over-year.
  • Eagle Pharmaceuticals, Inc. annual Depreciation for 2022 was $646K, a 15.4% decline from 2021.
  • Eagle Pharmaceuticals, Inc. annual Depreciation for 2021 was $764K, a 12.4% decline from 2020.
  • Eagle Pharmaceuticals, Inc. annual Depreciation for 2020 was $872K, a 10.3% decline from 2019.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $110K -$67K -37.9% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-09
Q1 2022 $177K -$13K -6.84% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q1 2021 $190K -$61K -24.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q1 2020 $251K -$252K -50.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q1 2019 $503K +$162K +47.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q1 2018 $341K +$145K +74% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q1 2017 $196K +$56K +40% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q1 2016 $140K +$128K +1067% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q1 2015 $12K -$17K -58.6% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $13K -$18K -58.1% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-15
Q1 2014 $29K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 $31K Oct 1, 2013 Dec 31, 2013 10-QT 2015-02-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.